LV10381B - Method for producing of solid medicinal preparations and solid medicinal preparations - Google Patents

Method for producing of solid medicinal preparations and solid medicinal preparations Download PDF

Info

Publication number
LV10381B
LV10381B LVP-93-32A LV930032A LV10381B LV 10381 B LV10381 B LV 10381B LV 930032 A LV930032 A LV 930032A LV 10381 B LV10381 B LV 10381B
Authority
LV
Latvia
Prior art keywords
ebselen
phenyl
solid
medicinal preparations
solid medicinal
Prior art date
Application number
LVP-93-32A
Other languages
English (en)
Latvian (lv)
Other versions
LV10381A (lv
Inventor
Rimer Axel
Seidel Juergen
Original Assignee
Nattermann A & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nattermann A & Cie filed Critical Nattermann A & Cie
Publication of LV10381A publication Critical patent/LV10381A/xx
Publication of LV10381B publication Critical patent/LV10381B/lv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D293/00—Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms
    • C07D293/10—Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms condensed with carbocyclic rings or ring systems
    • C07D293/12—Selenazoles; Hydrogenated selenazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Materials For Medical Uses (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
LVP-93-32A 1987-06-20 1993-01-15 Method for producing of solid medicinal preparations and solid medicinal preparations LV10381B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873720493 DE3720493A1 (de) 1987-06-20 1987-06-20 Arzneizubereitungen mit mikronisierten ebselen-kristallen

Publications (2)

Publication Number Publication Date
LV10381A LV10381A (lv) 1995-02-20
LV10381B true LV10381B (en) 1995-06-20

Family

ID=6330016

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-93-32A LV10381B (en) 1987-06-20 1993-01-15 Method for producing of solid medicinal preparations and solid medicinal preparations

Country Status (25)

Country Link
US (1) US5021242A (no)
EP (1) EP0296389B1 (no)
JP (1) JPH0713016B2 (no)
KR (1) KR970005322B1 (no)
AT (1) ATE69165T1 (no)
AU (1) AU603454B2 (no)
CA (1) CA1310906C (no)
DD (1) DD271056A5 (no)
DE (2) DE3720493A1 (no)
DK (1) DK173628B1 (no)
ES (1) ES2041736T3 (no)
FI (1) FI88256C (no)
GE (1) GEP19960342B (no)
GR (1) GR3003084T3 (no)
HU (1) HU200096B (no)
IE (1) IE63512B1 (no)
LT (1) LT3669B (no)
LV (1) LV10381B (no)
MX (1) MX169170B (no)
NO (1) NO175133C (no)
NZ (1) NZ225066A (no)
PT (1) PT87767B (no)
RU (1) RU1834657C (no)
UA (1) UA12648A (no)
ZA (1) ZA884025B (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5368864A (en) * 1988-11-25 1994-11-29 Henning Berlin Gmbh Chemie- Und Pharmawerk Formulation of oxypurinol and/or its alkali and alkaline earth salts
FR2684298B1 (fr) * 1991-12-03 1994-03-11 Rhone Poulenc Rorer Sa Nouvelles compositions pharmaceutiques solides a base de derives de lapiperidine substitues en 1,4.
JP2553434B2 (ja) * 1992-04-28 1996-11-13 第一製薬株式会社 粒状製剤
US6335036B1 (en) * 1993-10-27 2002-01-01 Daiichi Pharmaceutical Co., Ltd. Granular pharmaceutical preparation of ebselen
US5609883A (en) * 1994-09-16 1997-03-11 Advanced Technology Pharmaceuticals Corporation Compressed tablet transitory lubricant system
US5618845A (en) * 1994-10-06 1997-04-08 Cephalon, Inc. Acetamide derivative having defined particle size
KR100405116B1 (ko) * 1995-02-28 2004-02-05 아벤티스 파마슈티칼스 인크. 피페리디노알칸올화합물에대한약제학적조성물
CZ295461B6 (cs) * 1997-08-26 2005-08-17 Aventis Pharmaceuticals Inc. Farmaceutický prostředek ve formě dvouvrstvé tablety
US6242473B1 (en) * 1999-01-08 2001-06-05 Maxim Pharmaceuticals, Inc. Treatment and prevention of reactive oxygen metabolite-mediated cellular damage
EP1174423A4 (en) 1999-03-31 2008-03-19 Arne Holmgren SUBSTRATES FOR THIOREDOXINE REDUCTASE
AU4239302A (en) * 2001-06-28 2003-01-02 Pfizer Products Inc. Benzoic acid substituted benzopyrans for the treatment of atherosclerosis
US20040048931A1 (en) * 2002-07-12 2004-03-11 Craig Heacock Modafinil pharmaceutical compositions
MXPA05008088A (es) * 2003-02-24 2005-09-21 Mallinckrodt Inc Proceso mejorado para preparar benzhidril tioacetamida.
US20040253308A1 (en) * 2003-04-29 2004-12-16 Barr Laboratories, Inc. Surface-treated modafinil particles
US20080181966A1 (en) * 2006-10-18 2008-07-31 Cephalon, Inc. Modafinil pharmaceutical compositions
WO2008148064A1 (en) * 2007-05-23 2008-12-04 Sunesis Pharmaceuticals, Inc. Weight loss treatment
GB201102248D0 (en) 2011-02-09 2011-03-23 Isis Innovation Treatment of bipolar disorder
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith
TW201613888A (en) * 2014-09-26 2016-04-16 Helsinn Healthcare Sa Crystalline forms of an NK-1 antagonist
WO2022167778A1 (en) * 2021-02-02 2022-08-11 Haiku Therapeutics Ltd Ebselen as adenosine receptor modulator
WO2023240092A1 (en) * 2022-06-06 2023-12-14 Sound Pharmaceuticals Inc. Ebselen containing oral dosage forms

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3027073C2 (de) * 1980-07-17 1985-03-07 A. Nattermann & Cie GmbH, 5000 Köln Pharmazeutische Präparate, enthaltend 2-Phenyl-1,2-benzisoselenazol-3(2H)-on
DE3407511A1 (de) * 1984-03-01 1985-09-05 A. Nattermann & Cie GmbH, 5000 Köln Benzisoselenazolthione, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE3616923A1 (de) * 1986-05-20 1987-11-26 Nattermann A & Cie Neue pharmazeutische verwendung von 2-phenyl-1,2-benzisoselenazol-3(2h)-on
DE3620674A1 (de) * 1986-06-20 1987-12-23 Nattermann A & Cie Salbe zur behandlung von hauterkrankungen

Also Published As

Publication number Publication date
FI882912A0 (fi) 1988-06-17
DD271056A5 (de) 1989-08-23
DE3866033D1 (de) 1991-12-12
CA1310906C (en) 1992-12-01
HUT50037A (en) 1989-12-28
FI882912A (fi) 1988-12-21
GEP19960342B (en) 1996-02-20
NO175133B (no) 1994-05-30
NO882615D0 (no) 1988-06-14
NZ225066A (en) 1990-07-26
FI88256C (fi) 1993-04-26
NO882615L (no) 1988-12-21
AU1811688A (en) 1988-12-22
NO175133C (no) 1994-09-07
DK173628B1 (da) 2001-05-07
DK333388A (da) 1988-12-21
PT87767B (pt) 1992-10-30
AU603454B2 (en) 1990-11-15
FI88256B (fi) 1993-01-15
KR970005322B1 (ko) 1997-04-15
ATE69165T1 (de) 1991-11-15
LV10381A (lv) 1995-02-20
DK333388D0 (da) 1988-06-17
IE63512B1 (en) 1995-05-03
GR3003084T3 (en) 1993-02-17
IE881628L (en) 1988-12-20
ZA884025B (en) 1988-12-20
US5021242A (en) 1991-06-04
ES2041736T3 (es) 1996-07-16
LTIP903A (en) 1995-03-27
MX169170B (es) 1993-06-23
KR890000084A (ko) 1989-03-11
RU1834657C (ru) 1993-08-15
DE3720493A1 (de) 1989-01-26
HU200096B (en) 1990-04-28
EP0296389A1 (de) 1988-12-28
EP0296389B1 (de) 1991-11-06
PT87767A (pt) 1989-05-31
LT3669B (en) 1996-01-25
UA12648A (uk) 1997-02-28
JPH01100125A (ja) 1989-04-18
JPH0713016B2 (ja) 1995-02-15

Similar Documents

Publication Publication Date Title
LV10381B (en) Method for producing of solid medicinal preparations and solid medicinal preparations
PL318649A1 (en) Preparation to be administered by inhalation
NO174412C (no) Fremgangsmåte for fremstilling av en farmasöytisk formulering med programmert frigjöring for oral anvendelse
WO1994027557A3 (en) Pharmaceutical thermal infusion process
ATE115961T1 (de) Peptidverbindungen, verfahren zu deren herstellung und pharmazeutische präparate, die diese enthalten.
JPS5681546A (en) Secondary amines* their manufacture and medicinal composition containing them
ZA921702B (en) Trisubstituted triazines and pyrimidines,a process for their preparation and pharmaceutical compositions containing them
DE3688087D1 (de) Cephemverbindungen, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
CA1228818A (en) Treatment of seizure disorders and pharmaceutical compositions useful therein
EP0429187A1 (en) Enhanced bioavailability adsorbates
EP0551180B1 (en) Use of bucillamine for the manufacture of a medicament for the treatment of cystinuria
AU8029091A (en) Disubstituted polymethyleneimines, a process for the preparation thereof, and pharmaceutical compositions containing them
DE69803772T4 (de) Oral anzuwendende feste arzneizubereitungen mit modulierter wirkstoffabgabe enthaltend nicorandil und verfahren zu deren herstellung
HK1001822A1 (en) Medicinal form for oral application for the once-a-day treatment of hypertension by diltiazem hydrochloride
NZ315632A (en) Process for preparing solid dosage forms of very low-dose drugs comprising admixing 1-3% by weight of carrier particles with a solution of drug in water
GB1110397A (en) Ephedrine composition
JPS5661357A (en) Benzazepin derivative* its manufacture and medicinal composition containing it
JPS6440427A (en) 5-lipoxygenase action inhibitor
JPS56133290A (en) Nitrile compound and drug comprising it
GB1025151A (en) Disubstituted cyclohexanes
GB1187873A (en) Pharmaceutical Compositions Comprising a Cardiac Glycoside.
Kuzmin et al. Pharmacokinetics of zixorine administered in single and multiple doses.
Opavský et al. Clomipramine and clomipramine-analgesic combinations in rats: Antinociceptive activity, behavioral changes, brain serotonin and noradrenaline.
JPS5759809A (en) Cardiotonic agent
IT1238205B (it) Forma di somministrazione orale del fosfato di creatina e relative composizioni farmaceutiche.